PMEL and melanoma: First, peptide antigens frequently encountered in certain tumor types, such as Melan-A, gp100 peptide, and HMB-45 in melanoma, were isolated and injected into patients, so that they might be absorbed by DCs, which would, in turn, set off the lymphocytic immune response.